Sharon MacLachlan

610 total citations
23 papers, 426 citations indexed

About

Sharon MacLachlan is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Epidemiology. According to data from OpenAlex, Sharon MacLachlan has authored 23 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Sharon MacLachlan's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Diabetes Treatment and Management (4 papers) and Myasthenia Gravis and Thymoma (3 papers). Sharon MacLachlan is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Diabetes Treatment and Management (4 papers) and Myasthenia Gravis and Thymoma (3 papers). Sharon MacLachlan collaborates with scholars based in United Kingdom, United States and Switzerland. Sharon MacLachlan's co-authors include Mona Aeysha Khalid, Mireia Raluy-Callado, A. F Lazarev, Chiara Zecca, Debu Tripathy, B. Bergström, Sreeram V Ramagopalan, Claudio Gobbi, Rosaria Sacco and M. Budde and has published in prestigious journals such as Neurology, Cancer Research and Diabetes.

In The Last Decade

Sharon MacLachlan

23 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon MacLachlan United Kingdom 11 121 106 86 86 67 23 426
Shakeel Jamal United States 11 54 0.4× 45 0.4× 81 0.9× 51 0.6× 20 0.3× 51 444
András Szabó Hungary 12 37 0.3× 62 0.6× 31 0.4× 42 0.5× 64 1.0× 32 415
Hélène Béhal France 13 148 1.2× 85 0.8× 40 0.5× 25 0.3× 42 0.6× 35 388
H. J. Roth Germany 10 28 0.2× 138 1.3× 67 0.8× 35 0.4× 102 1.5× 16 452
Maria Grazia Caprio Italy 14 67 0.6× 23 0.2× 97 1.1× 38 0.4× 30 0.4× 38 484
Liza M. Cohen United States 12 26 0.2× 80 0.8× 93 1.1× 32 0.4× 28 0.4× 51 422
Francesco Pio Cafarelli Italy 10 72 0.6× 26 0.2× 25 0.3× 62 0.7× 147 2.2× 28 482
Keiko Yamagami Japan 14 98 0.8× 66 0.6× 23 0.3× 37 0.4× 80 1.2× 60 640
Alper Cesmebasi Grenada 11 63 0.5× 83 0.8× 29 0.3× 41 0.5× 24 0.4× 16 437
Ertap Akoğlu Türkiye 15 53 0.4× 42 0.4× 27 0.3× 40 0.5× 106 1.6× 36 507

Countries citing papers authored by Sharon MacLachlan

Since Specialization
Citations

This map shows the geographic impact of Sharon MacLachlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon MacLachlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon MacLachlan more than expected).

Fields of papers citing papers by Sharon MacLachlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon MacLachlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon MacLachlan. The network helps show where Sharon MacLachlan may publish in the future.

Co-authorship network of co-authors of Sharon MacLachlan

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon MacLachlan. A scholar is included among the top collaborators of Sharon MacLachlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon MacLachlan. Sharon MacLachlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Linda, Sophie Graham, Sharon MacLachlan, Alex Exuzides, & Saiju Jacob. (2022). A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. BMC Neurology. 22(1). 172–172. 30 indexed citations
2.
Berger, Ariel, Jimena Goldstine, Cheriel J. Hofstad, et al.. (2020). Incidence of urinary tract infection following initiation of intermittent catheterization among patients with recent spinal cord injury in Germany and the Netherlands. Journal of Spinal Cord Medicine. 45(3). 461–471. 11 indexed citations
3.
Gobbi, Claudio, Giulio Disanto, Rosaria Sacco, et al.. (2020). Increasing Trends of Cancer Diagnoses in People with Multiple Sclerosis (1512). Neurology. 94(15_supplement). 2 indexed citations
4.
Tran, Trung N., Sharon MacLachlan, Wesley L. Hicks, et al.. (2020). Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 338–346.e3. 27 indexed citations
5.
Zecca, Chiara, Giulio Disanto, Rosaria Sacco, et al.. (2020). Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study. Journal of Neurology. 268(3). 817–824. 8 indexed citations
6.
Horne, Laura, Akhtar Ashfaq, Sharon MacLachlan, et al.. (2019). Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England. BMC Nephrology. 20(1). 85–85. 24 indexed citations
7.
Harris, Linda, Sophie Graham, Sharon MacLachlan, Alex Exuzides, & Saiju Jacob. (2019). Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. Journal of Medical Economics. 22(7). 691–697. 11 indexed citations
8.
Cherney, David Z.I., Enrico Repetto, David C. Wheeler, et al.. (2019). Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus. American Journal of Nephrology. 51(1). 74–82. 39 indexed citations
9.
10.
Graham, Sophie, Sharon MacLachlan, Alex Exuzides, et al.. (2018). PMS76 - HEALTHCARE RESOURCE UTILISATION ASSOCIATED WITH REFRACTORY MYASTHENIA GRAVIS (MG), IN COMPARISON TO NON-REFRACTORY MG PATIENTS IN ENGLAND: A RETROSPECTIVE COHORT STUDY.. Value in Health. 21. S300–S301. 2 indexed citations
11.
Gray, Jhanelle E., Bharat Thakrar, Ping‐Hui Sun, et al.. (2018). Treatment (tx) patterns in patients (pts) with lung cancer starting 1st or 2nd generation (1G/2G) EGFR-TKI: A US insurance claims database analysis. Annals of Oncology. 29. ix156–ix157. 6 indexed citations
12.
Disanto, Giulio, Chiara Zecca, Sharon MacLachlan, et al.. (2018). Prodromal symptoms of multiple sclerosis in primary care. Annals of Neurology. 83(6). 1162–1173. 114 indexed citations
13.
Raluy-Callado, Mireia, Andrew Cox, Sharon MacLachlan, et al.. (2018). A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom. Current Medical Research and Opinion. 34(7). 1317–1324. 13 indexed citations
14.
Qin, Lei, Laura Horne, Akhtar Ashfaq, et al.. (2017). SP321HEALTH CARE RESOURCE UTILIZATION FOLLOWING HYPERKALEMIA IN ADULTS IN THE UK. Nephrology Dialysis Transplantation. 32(suppl_3). iii216–iii216. 1 indexed citations
15.
Brunt, Kate Van, Bradley Curtis, T. Iványi, et al.. (2016). Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin. Diabetes Therapy. 7(4). 793–807. 4 indexed citations
16.
Ramagopalan, Sreeram V, et al.. (2016). COPD exacerbations by disease severity in England. International Journal of COPD. 11. 697–697. 23 indexed citations
17.
Raluy-Callado, Mireia, et al.. (2015). Resource Use And Exacerbations Of Chronic Obstructive Pulmonary Disease (Copd) By Gold Categories. Value in Health. 18(7). A506–A507. 1 indexed citations
18.
Raluy-Callado, Mireia, Dimitra Lambrelli, Sharon MacLachlan, & Mona Aeysha Khalid. (2015). Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. International Journal of COPD. 10. 925–925. 32 indexed citations
19.
Raluy-Callado, Mireia, et al.. (2014). Epidemiology and Severity of Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK). Value in Health. 17(7). A590–A590. 2 indexed citations
20.
Tripathy, Debu, A. F Lazarev, Sharon MacLachlan, et al.. (2004). Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial. Annals of Oncology. 15(5). 743–750. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shakeel Jamal Breakdown of academic impact, for papers by András Szabó Breakdown of academic impact, for papers by Hélène Béhal Breakdown of academic impact, for papers by H. J. Roth Breakdown of academic impact, for papers by Maria Grazia Caprio Breakdown of academic impact, for papers by Liza M. Cohen Breakdown of academic impact, for papers by Francesco Pio Cafarelli Breakdown of academic impact, for papers by Keiko Yamagami Breakdown of academic impact, for papers by Alper Cesmebasi Breakdown of academic impact, for papers by Ertap Akoğlu
Rankless by CCL
2026